supported by grants from the National Natural Science Foundation of China (30630023);the Science Fund for Creative Research Groups of the National Natural Science Foundation of China (81121002)
BACKGROUND: For nearly three decades, extracorporeal bioartificial liver (BAL) support systems have been anticipated as promising tools for the treatment of liver failure. However, these systems are still far from cli...
supported by grants from the NationalS&T Major Project for Infectious Disease Control of China(2008ZX10002-005);the National High Technology Research and Development Program of China(2006AA02A140);the National Natural Science Foundation of China(30630023);Zhejiang Health Science Foundation(2009A076)
BACKGROUND: The bioartificial liver is anticipated to be a promising alternative choice for patients with liver failure. Toxic substances which accumulate in the patients' plasma exert deleterious effects on hepatocyt...
supported by grants from the NationalS&T Major Project for Infectious Disease Control of China(2008ZX10002-005);the National High Technology Research and Development Program of China(2006AA02A140);the National Natural Science Foundation of China(30630023);Zhejiang Health Science Foundation(2009A076)
BACKGROUND: Acute liver failure (ALF) remains a dramatic and unpredictable disease with high morbidity and mortality. Early and accurate prognostic assessment of patients with ALF is critically important for optimum c...
supported by grants from the National High Technolgoy Research and Development(863)Program of China(2006AA02A140);the National Natural Science Foundation of China(30630023);Zhejiang Health Science Foundation(2007A081)
BACKGROUND: Bioartificial liver support systems are becoming an effective therapy for hepatic failure. Bioreactors, as key devices in these systems, can provide a favorable growth and metabolic environment, mass excha...